Evaluation of risk factors for long-term atrial fibrillation development in patients undergoing typical atrial flutter ablation: a multicenter pilot study.

Untersuchung von Risikofaktoren für die langfristige Entstehung von Vorhofflimmern bei Patienten mit Ablation wegen typischen Vorhofflatterns: eine multizentrische Pilotstudie.
Ablation Atrial fibrillation Atrial flutter Cavotricuspid isthmus

Journal

Herz
ISSN: 1615-6692
Titre abrégé: Herz
Pays: Germany
ID NLM: 7801231

Informations de publication

Date de publication:
13 Aug 2024
Historique:
received: 26 03 2024
accepted: 15 07 2024
revised: 08 07 2024
medline: 14 8 2024
pubmed: 14 8 2024
entrez: 14 8 2024
Statut: aheadofprint

Résumé

Atrial flutter (AFL) and atrial fibrillation (AF) are the most commonly detected supraventricular arrhythmias and share similar pathophysiological mechanisms. After the successful ablation of AFL, AF frequently occurs in the long-term follow-up. As emphasized in some studies, certain mechanisms seem to predispose to the development of AF in AFL patients, and approximately 20% of these patients have accompanying AFL. We aimed to analyze independent risk factors that predict the development of AF in patients who underwent typical AFL ablation. This was a multicenter, cross-sectional, and retrospective study. A total of 442 patients who underwent typical AFL ablation at three different centers between January 1, 2018 and January 1, 2022 were included retrospectively. After the ablation procedure the patients were divided into those who developed AF and those who did not. The patients were followed up for an average of 12 (4-20) months. In the post-procedural period, atrial arrhythmias were investigated with 24‑h Holter and ECG at 1 month, 6 months, and 12 months and then at 6‑month intervals thereafter. Overall, AF developed in 206 (46.6%) patients in the long-term follow-up. Age, hypertension (HT), obstructive sleep apnea syndrome (OSAS), previous cerebrovascular accident (CVA), left atrium anteroposterior diameter, severe mitral regurgitation, hemoglobin, blood glucose, and HbA1c values were found to be significant in univariable analysis. According to multivariable analysis, HT (p = 0.014; HR: 1.483 [1.084-2.030]), OSAS (p = 0.008; HR: 1.520 [1.117-2.068]) and previous CVA (p = 0.038; HR: 1.749 [1.031-2.968]) were independently associated with the development of AF in AFL patients who underwent ablation procedure. In the present study, we found that HT, OSAS, and previous CVA were independently correlated with the development of AF in the long-term follow-up of patients who underwent typical AFL ablation. We consider that AFL patients with such risk factors should be followed up closely following cavotricuspid isthmus ablation for the development of AF. HINTERGRUND: Vorhofflattern (VFL) und Vorhofflimmern (VF) sind die am häufigsten diagnostizierten supraventrikulären Arrhythmien und haben ähnliche pathophysiologische Mechanismen. Nach erfolgreicher Ablation des VFL tritt während des Langzeit-Follow-up oftmals VF auf. Wie in einigen Studien herausgestellt wurde, scheinen bestimmte Mechanismen für die Entstehung von VF bei VFL-Patienten zu prädisponieren, und bei annähernd 20% dieser Patienten besteht ein begleitendes VFL. ZIEL: Ziel der vorliegenden Arbeit war die Untersuchung unabhängiger Risikofaktoren, die Prädiktoren für die Entstehung von VF bei Patienten mit Ablation wegen typischem VFL sind. Es handelte sich um eine retrospektive multizentrische Querschnittstudie. Darin wurden retrospektiv 442 Patienten eingeschlossen, bei denen in 3 verschiedenen Zentren zwischen 1. Januar 2018 und 1. Januar 2022 eine Ablation wegen typischem VFL durchgeführt wurde. Nach der Ablation wurden die Patienten unterteilt in diejenigen, welche VF entwickelten, und diejenigen ohne VF. Im Durchschnitt wurden die Patienten 12 (4–20) Monate lang nachbeobachtet. In der Phase nach dem Eingriff wurden atriale Arrhythmien mittels 24-h-Langzeit-EKG und EKG nach einem Monat, 6 und 12 Monaten und danach in 6‑monatigen Abständen untersucht. Während des Langzeit-Follow-up trat ein VF bei 206 (46,6%) Patienten auf. Alter, Hypertonie (HT), obstruktives Schlafapnoesyndrom (OSAS), frühere zerebrovaskuläre Ereignisse (CVA), linksatrialer anteroposteriorer Durchmesser, schwere Mitralregurgitation, Hämoglobin‑, Blutzucker- und HbA1c-Wert wurden in der univariablen Analyse als signifikant eingestuft. Gemäß der multivariablen Analyse waren HT (p = 0,014; Hazard Ratio, HR: 1,483 [1,084–2,030]), OSAS (p = 0,008; HR: 1,520 [1,117–2,068]) und frühere CVA (p = 0,038; HR: 1,749 [1,031–2,968]) unabhängig mit der Entstehung von VF bei VFL-Patienten mit Zustand nach Ablation assoziiert. In der vorliegenden Studie stellte sich heraus, dass HT, OSAS und frühere CVA unabhängig mit der Entstehung von VF im Langzeit-Follow-up bei Patienten korreliert waren, bei denen eine Ablation wegen typischem VFL erfolgte. Den Autoren zufolge sollten VFL-Patienten mit solchen Risikofaktoren nach einer kavotrikuspidalen Isthmusablation engmaschig in Bezug auf die Entstehung von VF nachuntersucht werden.

Sections du résumé

BACKGROUND BACKGROUND
Atrial flutter (AFL) and atrial fibrillation (AF) are the most commonly detected supraventricular arrhythmias and share similar pathophysiological mechanisms. After the successful ablation of AFL, AF frequently occurs in the long-term follow-up. As emphasized in some studies, certain mechanisms seem to predispose to the development of AF in AFL patients, and approximately 20% of these patients have accompanying AFL.
PURPOSE OBJECTIVE
We aimed to analyze independent risk factors that predict the development of AF in patients who underwent typical AFL ablation.
METHODS METHODS
This was a multicenter, cross-sectional, and retrospective study. A total of 442 patients who underwent typical AFL ablation at three different centers between January 1, 2018 and January 1, 2022 were included retrospectively. After the ablation procedure the patients were divided into those who developed AF and those who did not. The patients were followed up for an average of 12 (4-20) months. In the post-procedural period, atrial arrhythmias were investigated with 24‑h Holter and ECG at 1 month, 6 months, and 12 months and then at 6‑month intervals thereafter.
RESULTS RESULTS
Overall, AF developed in 206 (46.6%) patients in the long-term follow-up. Age, hypertension (HT), obstructive sleep apnea syndrome (OSAS), previous cerebrovascular accident (CVA), left atrium anteroposterior diameter, severe mitral regurgitation, hemoglobin, blood glucose, and HbA1c values were found to be significant in univariable analysis. According to multivariable analysis, HT (p = 0.014; HR: 1.483 [1.084-2.030]), OSAS (p = 0.008; HR: 1.520 [1.117-2.068]) and previous CVA (p = 0.038; HR: 1.749 [1.031-2.968]) were independently associated with the development of AF in AFL patients who underwent ablation procedure.
CONCLUSION CONCLUSIONS
In the present study, we found that HT, OSAS, and previous CVA were independently correlated with the development of AF in the long-term follow-up of patients who underwent typical AFL ablation. We consider that AFL patients with such risk factors should be followed up closely following cavotricuspid isthmus ablation for the development of AF.
ZUSAMMENFASSUNG UNASSIGNED
HINTERGRUND: Vorhofflattern (VFL) und Vorhofflimmern (VF) sind die am häufigsten diagnostizierten supraventrikulären Arrhythmien und haben ähnliche pathophysiologische Mechanismen. Nach erfolgreicher Ablation des VFL tritt während des Langzeit-Follow-up oftmals VF auf. Wie in einigen Studien herausgestellt wurde, scheinen bestimmte Mechanismen für die Entstehung von VF bei VFL-Patienten zu prädisponieren, und bei annähernd 20% dieser Patienten besteht ein begleitendes VFL. ZIEL: Ziel der vorliegenden Arbeit war die Untersuchung unabhängiger Risikofaktoren, die Prädiktoren für die Entstehung von VF bei Patienten mit Ablation wegen typischem VFL sind.
METHODEN METHODS
Es handelte sich um eine retrospektive multizentrische Querschnittstudie. Darin wurden retrospektiv 442 Patienten eingeschlossen, bei denen in 3 verschiedenen Zentren zwischen 1. Januar 2018 und 1. Januar 2022 eine Ablation wegen typischem VFL durchgeführt wurde. Nach der Ablation wurden die Patienten unterteilt in diejenigen, welche VF entwickelten, und diejenigen ohne VF. Im Durchschnitt wurden die Patienten 12 (4–20) Monate lang nachbeobachtet. In der Phase nach dem Eingriff wurden atriale Arrhythmien mittels 24-h-Langzeit-EKG und EKG nach einem Monat, 6 und 12 Monaten und danach in 6‑monatigen Abständen untersucht.
ERGEBNISSE UNASSIGNED
Während des Langzeit-Follow-up trat ein VF bei 206 (46,6%) Patienten auf. Alter, Hypertonie (HT), obstruktives Schlafapnoesyndrom (OSAS), frühere zerebrovaskuläre Ereignisse (CVA), linksatrialer anteroposteriorer Durchmesser, schwere Mitralregurgitation, Hämoglobin‑, Blutzucker- und HbA1c-Wert wurden in der univariablen Analyse als signifikant eingestuft. Gemäß der multivariablen Analyse waren HT (p = 0,014; Hazard Ratio, HR: 1,483 [1,084–2,030]), OSAS (p = 0,008; HR: 1,520 [1,117–2,068]) und frühere CVA (p = 0,038; HR: 1,749 [1,031–2,968]) unabhängig mit der Entstehung von VF bei VFL-Patienten mit Zustand nach Ablation assoziiert.
SCHLUSSFOLGERUNG UNASSIGNED
In der vorliegenden Studie stellte sich heraus, dass HT, OSAS und frühere CVA unabhängig mit der Entstehung von VF im Langzeit-Follow-up bei Patienten korreliert waren, bei denen eine Ablation wegen typischem VFL erfolgte. Den Autoren zufolge sollten VFL-Patienten mit solchen Risikofaktoren nach einer kavotrikuspidalen Isthmusablation engmaschig in Bezug auf die Entstehung von VF nachuntersucht werden.

Autres résumés

Type: Publisher (ger)
HINTERGRUND: Vorhofflattern (VFL) und Vorhofflimmern (VF) sind die am häufigsten diagnostizierten supraventrikulären Arrhythmien und haben ähnliche pathophysiologische Mechanismen. Nach erfolgreicher Ablation des VFL tritt während des Langzeit-Follow-up oftmals VF auf. Wie in einigen Studien herausgestellt wurde, scheinen bestimmte Mechanismen für die Entstehung von VF bei VFL-Patienten zu prädisponieren, und bei annähernd 20% dieser Patienten besteht ein begleitendes VFL. ZIEL: Ziel der vorliegenden Arbeit war die Untersuchung unabhängiger Risikofaktoren, die Prädiktoren für die Entstehung von VF bei Patienten mit Ablation wegen typischem VFL sind.

Identifiants

pubmed: 39138662
doi: 10.1007/s00059-024-05261-2
pii: 10.1007/s00059-024-05261-2
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

Références

Benjamin EJ, Muntner P, Alonso A et al (2019) Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation 139(10):e56–e528. https://doi.org/10.1161/CIR.0000000000000659 (published correction appears in Circulation. 2020 Jan 14;141(2):e33)
doi: 10.1161/CIR.0000000000000659 pubmed: 30700139
Waldo AL, Feld GK (2008) Inter-relationships of atrial fibrillation and atrial flutter mechanisms and clinical implications. J Am Coll Cardiol 51(8):779–786. https://doi.org/10.1016/j.jacc.2007.08.066
doi: 10.1016/j.jacc.2007.08.066 pubmed: 18294560
Waldo AL (2017) Atrial fibrillation and atrial flutter: Two sides of the same coin! Int J Cardiol 240:251–252. https://doi.org/10.1016/j.ijcard.2017.02.146
doi: 10.1016/j.ijcard.2017.02.146 pubmed: 28606679
Chung MK, Refaat M, Shen WK et al (2020) Atrial Fibrillation: JACC Council Perspectives. J Am Coll Cardiol 75(14):1689–1713. https://doi.org/10.1016/j.jacc.2020.02.025
doi: 10.1016/j.jacc.2020.02.025 pubmed: 32273035
Anselme F, Savouré A, Clémenty N et al (2021) Preventing atrial fibrillation by combined right isthmus ablation and cryoballoon pulmonary vein isolation in patients with typical atrial flutter: PAF-CRIOBLAF study. J Arrhythm 37(5):1303–1310. https://doi.org/10.1002/joa3.12626
doi: 10.1002/joa3.12626 pubmed: 34621429 pmcid: 8485809
Stempfel S, Aeschbacher S, Blum S et al (2020) Symptoms and quality of life in patients with coexistent atrial fibrillation and atrial flutter. Int J Cardiol Heart Vasc 29:100556. https://doi.org/10.1016/j.ijcha.2020.100556
doi: 10.1016/j.ijcha.2020.100556 pubmed: 32577496 pmcid: 7303549
Gupta D, Ding WY, Calvert P et al (2023) Cryoballoon Pulmonary Vein Isolation as First-Line Treatment for Typical Atrial Flutter. Heart 109(5):364–371. https://doi.org/10.1136/heartjnl-2022-321729
doi: 10.1136/heartjnl-2022-321729 pubmed: 36396438
Fu B, Ran B, Zhang H, Luo Y, Wang J (2021) Prophylactic pulmonary vein isolation in typical atrial flutter patients without atrial fibrillation: a systematic review and meta-analysis of randomized trials. J Interv Card Electrophysiol 60(3):529–533. https://doi.org/10.1007/s10840-020-00772-4
doi: 10.1007/s10840-020-00772-4 pubmed: 32424664
Hindricks G, Potpara T, Dagres N et al (2020) ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 42(5):373–498. https://doi.org/10.1093/eurheartj/ehaa612 ([published correction appears in Eur Heart J. 2021 Feb 1;42(5):507] [published correction appears in Eur Heart J. 2021 Feb 1;42(5):546–547] [published correction appears in Eur Heart J. 2021 Oct 21;42(40):4194])
doi: 10.1093/eurheartj/ehaa612
Mittal S, Pokushalov E, Romanov A et al (2013) Long-term ECG monitoring using an implantable loop recorder for the detection of atrial fibrillation after cavotricuspid isthmus ablation in patients with atrial flutter. Heart Rhythm 10(11):1598–1604. https://doi.org/10.1016/j.hrthm.2013.07.044
doi: 10.1016/j.hrthm.2013.07.044 pubmed: 23911429
Pérez FJ, Schubert CM, Parvez B, Pathak V, Ellenbogen KA, Wood MA (2009) Long-term outcomes after catheter ablation of cavo-tricuspid isthmus dependent atrial flutter: a meta-analysis. Circ Arrhythm Electrophysiol 2(4):393–401. https://doi.org/10.1161/CIRCEP.109.871665
doi: 10.1161/CIRCEP.109.871665 pubmed: 19808495
Mohanty S, Mohanty P, Di Biase L et al (2013) Results from a single-blind, randomized study comparing the impact of different ablation approaches on long-term procedure outcome in coexistent atrial fibrillation and flutter (APPROVAL). Circulation 127(18):1853–1860. https://doi.org/10.1161/CIRCULATIONAHA.113.001855
doi: 10.1161/CIRCULATIONAHA.113.001855 pubmed: 23572499
Voight J, Akkaya M, Somasundaram P et al (2014) Risk of new-onset atrial fibrillation and stroke after radiofrequency ablation of isolated, typical atrial flutter. Heart Rhythm 11(11):1884–1889. https://doi.org/10.1016/j.hrthm.2014.06.038
doi: 10.1016/j.hrthm.2014.06.038 pubmed: 24998999
Chen K, Bai R, Deng W et al (2015) HATCH score in the prediction of new-onset atrial fibrillation after catheter ablation of typical atrial flutter. Heart Rhythm 12(7):1483–1489. https://doi.org/10.1016/j.hrthm.2015.04.008
doi: 10.1016/j.hrthm.2015.04.008 pubmed: 25850017
Romero J, Diaz JC, Di Biase L et al (2017) Atrial fibrillation inducibility during cavotricuspid isthmus-dependent atrial flutter ablation as a predictor of clinical atrial fibrillation. A meta-analysis. J Interv Card Electrophysiol 48(3):307–315. https://doi.org/10.1007/s10840-016-0211-9
doi: 10.1007/s10840-016-0211-9 pubmed: 28070875
De Bortoli A, Shi LB, Ohm OJ et al (2017) Incidence and clinical predictors of subsequent atrial fibrillation requiring additional ablation after cavotricuspid isthmus ablation for typical atrial flutter. Scand Cardiovasc J 51(3):123–128. https://doi.org/10.1080/14017431.2017.1304570
doi: 10.1080/14017431.2017.1304570 pubmed: 28335638
Li JH, Xie HY, Chen YQ et al (2021) Risk of New-Onset Atrial Fibrillation Post-cavotricuspid Isthmus Ablation in Typical Atrial Flutter Without History of Atrial Fibrillation. Front Physiol 12:763478. https://doi.org/10.3389/fphys.2021.763478
doi: 10.3389/fphys.2021.763478 pubmed: 34916957 pmcid: 8669788
Aune D, Mahamat-Saleh Y, Kobeissi E, Feng T, Heath AK, Janszky I (2023) Blood pressure, hypertension and the risk of atrial fibrillation: a systematic review and meta-analysis of cohort studies. Eur J Epidemiol 38(2):145–178. https://doi.org/10.1007/s10654-022-00914-0
doi: 10.1007/s10654-022-00914-0 pubmed: 36626102 pmcid: 9905193
Nazarzadeh M, Pinho-Gomes AC, Bidel Z et al (2021) Genetic susceptibility, elevated blood pressure, and risk of atrial fibrillation: a Mendelian randomization study. Genome Med 13(1):38. https://doi.org/10.1186/s13073-021-00849-3
doi: 10.1186/s13073-021-00849-3 pubmed: 33663581 pmcid: 7934395
Aronson D, Shalev V, Katz R, Chodick G, Mutlak D (2018) Risk Score for Prediction of 10-Year Atrial Fibrillation: A Community-Based Study. Thromb Haemost 118(9):1556–1563. https://doi.org/10.1055/s-0038-1668522
doi: 10.1055/s-0038-1668522 pubmed: 30103243
Khurshid S, Choi SH, Weng LC et al (2018) Frequency of Cardiac Rhythm Abnormalities in a Half Million Adults. Circ Arrhythm Electrophysiol 11(7):e6273. https://doi.org/10.1161/CIRCEP.118.006273
doi: 10.1161/CIRCEP.118.006273 pubmed: 29954742 pmcid: 6051725
Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE (1995) The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med 98(5):476–484. https://doi.org/10.1016/S0002-9343(99)80348-9
doi: 10.1016/S0002-9343(99)80348-9 pubmed: 7733127
Friberg J, Buch P, Scharling H, Gadsbphioll N, Jensen GB (2003) Rising rates of hospital admissions for atrial fibrillation. Epidemiology 14(6):666–672. https://doi.org/10.1097/01.ede.0000091649.26364.c0
doi: 10.1097/01.ede.0000091649.26364.c0 pubmed: 14569181
Alonso A, Krijthe BP, Aspelund T et al (2013) Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium. J Am Heart Assoc 2(2):e102. https://doi.org/10.1161/JAHA.112.000102
doi: 10.1161/JAHA.112.000102 pubmed: 23537808 pmcid: 3647274
Kolek MJ, Graves AJ, Xu M et al (2016) Evaluation of a Prediction Model for the Development of Atrial Fibrillation in a Repository of Electronic Medical Records. JAMA Cardiol 1(9):1007–1013. https://doi.org/10.1001/jamacardio.2016.3366
doi: 10.1001/jamacardio.2016.3366 pubmed: 27732699 pmcid: 5293184
Hamada R, Muto S (2019) Simple risk model and score for predicting of incident atrial fibrillation in Japanese. J Cardiol 73(1):65–72. https://doi.org/10.1016/j.jjcc.2018.06.005
doi: 10.1016/j.jjcc.2018.06.005 pubmed: 30064946
Iwasaki YK (2022) Mechanism and management of atrial fibrillation in the patients with obstructive sleep apnea. J Arrhythm 38(6):974–980. https://doi.org/10.1002/joa3.12784
doi: 10.1002/joa3.12784 pubmed: 36524043 pmcid: 9745489
Linz D, Schotten U, Neuberger HR, Böhm M, Wirth K (2011) Negative tracheal pressure during obstructive respiratory events promotes atrial fibrillation by vagal activation. Heart Rhythm 8(9):1436–1443. https://doi.org/10.1016/j.hrthm.2011.03.053
doi: 10.1016/j.hrthm.2011.03.053 pubmed: 21457790
Iwasaki YK, Nishida K, Kato T, Nattel S (2011) Atrial fibrillation pathophysiology: implications for management. Circulation 124(20):2264–2274. https://doi.org/10.1161/CIRCULATIONAHA.111.019893
doi: 10.1161/CIRCULATIONAHA.111.019893 pubmed: 22083148
Monahan K, Storfer-Isser A, Mehra R et al (2009) Triggering of nocturnal arrhythmias by sleep-disordered breathing events. J Am Coll Cardiol 54(19):1797–1804. https://doi.org/10.1016/j.jacc.2009.06.038
doi: 10.1016/j.jacc.2009.06.038 pubmed: 19874994 pmcid: 2814244
Iwasaki YK, Kato T, Xiong F et al (2014) Atrial fibrillation promotion with long-term repetitive obstructive sleep apnea in a rat model. J Am Coll Cardiol 64(19):2013–2023. https://doi.org/10.1016/j.jacc.2014.05.077
doi: 10.1016/j.jacc.2014.05.077 pubmed: 25440097
Anter E, Di Biase L, Contreras-Valdes FM et al (2017) Atrial Substrate and Triggers of Paroxysmal Atrial Fibrillation in Patients With Obstructive Sleep Apnea. Circ Arrhythm Electrophysiol 10(11):e5407. https://doi.org/10.1161/CIRCEP.117.005407
doi: 10.1161/CIRCEP.117.005407 pubmed: 29133380 pmcid: 5726812
Affas Z, Affas S, Tabbaa K (2022) Continuous positive airway pressure reduces the incidence of atrial fibrillation in patients with obstructive sleep apnea: A Meta-Analysis and Systematic Review. Spartan Med Res J 7(2):34521. https://doi.org/10.51894/001c.34521
doi: 10.51894/001c.34521 pubmed: 36128027 pmcid: 9448661
Choi SE, Sagris D, Hill A, Lip GYH, Abdul-Rahim AH (2023) Atrial fibrillation and stroke. Expert Rev Cardiovasc Ther 21(1):35–56. https://doi.org/10.1080/14779072.2023.2160319
doi: 10.1080/14779072.2023.2160319 pubmed: 36537565
Poh MQW, Tham CH, Chee JDMS et al (2023) Predicting Atrial Fibrillation after Ischemic Stroke: Clinical, Genetics, and Electrocardiogram Modelling. Cerebrovasc Dis Extra 13(1):9–17. https://doi.org/10.1159/000528516
doi: 10.1159/000528516 pubmed: 36521445
Amberger U, Lippert J, Mujanovic A et al (2022) Association of Chronic Covert Cerebral Infarctions and White Matter Hyperintensities With Atrial Fibrillation Detection on Post-Stroke Cardiac Rhythm Monitoring: A Cohort Study. J Am Heart Assoc 11(24):e26962. https://doi.org/10.1161/JAHA.122.026962
doi: 10.1161/JAHA.122.026962 pubmed: 36515235 pmcid: 9798803
Favilla CG, Ingala E, Jara J et al (2015) Predictors of finding occult atrial fibrillation after cryptogenic stroke. Stroke 46(5):1210–1215. https://doi.org/10.1161/STROKEAHA.114.007763
doi: 10.1161/STROKEAHA.114.007763 pubmed: 25851771
Bertaglia E, Zoppo F, Bonso A et al (2004) Long term follow up of radiofrequency catheter ablation of atrial flutter: clinical course and predictors of atrial fibrillation occurrence. Heart 90(1):59–63. https://doi.org/10.1136/heart.90.1.59
doi: 10.1136/heart.90.1.59 pubmed: 14676244 pmcid: 1768035
Da Costa A, Romeyer C, Mourot S et al (2002) Factors associated with early atrial fibrillation after ablation of common atrial flutter. A single centre prospective study. Eur Heart J 23(6):498–506. https://doi.org/10.1053/euhj.2001.2819
doi: 10.1053/euhj.2001.2819 pubmed: 11863353
Linhart M, Bellmann B, Mittmann-Braun E et al (2009) Comparison of cryoballoon and radiofrequency ablation of pulmonary veins in 40 patients with paroxysmal atrial fibrillation: a case-control study. J Cardiovasc Electrophysiol 20(12):1343–1348. https://doi.org/10.1111/j.1540-8167.2009.01560.x
doi: 10.1111/j.1540-8167.2009.01560.x pubmed: 19656254
Orczykowski M, Urbanek P, Bodalski R et al (2024) Acute safety and efficacy of pulse field ablation for atrial fibrillation in a Polish cohort of patients. Kardiol Pol. https://doi.org/10.33963/v.phj.100690
doi: 10.33963/v.phj.100690 pubmed: 38845427

Auteurs

Ahmet Çağdaş Yumurtaş (AÇ)

Department of Cardiology, Kars Harakani State Hospital, Kars, Turkey. ayumurtas@hotmail.com.

Levent Pay (L)

Department of Cardiology, Ardahan State Hospital, Ardahan, Turkey.

Ozan Tezen (O)

Department of Cardiology, Bayrampaşa State Hospital, Istanbul, Turkey.

Tuğba Çetin (T)

Department of Cardiology, Dr. Siyami Ersek Thoracic and Cardiovascular Training and Research Hospital, Istanbul, Turkey.

Furkan Fatih Yücedağ (FF)

Department of Cardiology, Dr. Siyami Ersek Thoracic and Cardiovascular Training and Research Hospital, Istanbul, Turkey.

Ertan Arter (E)

Department of Cardiology, Dr. Siyami Ersek Thoracic and Cardiovascular Training and Research Hospital, Istanbul, Turkey.

Hikmet Kadıoğlu (H)

Department of Cardiology, Dr. Siyami Ersek Thoracic and Cardiovascular Training and Research Hospital, Istanbul, Turkey.

Hüseyin Akgün (H)

Department of Cardiology, Başakşehir Çam ve Sakura City Hospital, Istanbul, Turkey.

Eyüp Özkan (E)

Department of Cardiology, Başakşehir Çam ve Sakura City Hospital, Istanbul, Turkey.

Abdulkadir Uslu (A)

Department of Cardiology, Kartal Koşuyolu Heart and Research Hospital, Istanbul, Turkey.

Ayhan Küp (A)

Department of Cardiology, Kartal Koşuyolu Heart and Research Hospital, Istanbul, Turkey.

Faysal Şaylık (F)

Department of Cardiology, Van Traning and Research Hospital, Van, Turkey.

Tufan Çınar (T)

Department of Internal Medicine, University of Maryland Medical Center Midtown Campus, Baltimore, MD, USA.

Mert İlker Hayıroğlu (Mİ)

Department of Cardiology, Dr. Siyami Ersek Thoracic and Cardiovascular Training and Research Hospital, Istanbul, Turkey.

Classifications MeSH